Sitemap | Contact Us  

Welcome To Taj Pharmaceuticals Ltd API      

About Worldwide  |     FAQs    |    Careers     | |        Media Center  |  |    Taj Pharmaceuticals  World   | |     TAJ Group 


      © 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved

Rabeprazole Sodium

      India              Latin America/ Caribbean            Africa & Middle East              Asia              Russia              Europe  

Active Pharmaceutical Ingredients  TAJ PHARMACEUTICALS LIMITED

Rabeprazole Sodium Manufacturers in India Suppliers Rabeprazole Sodium Exporters Distributors Rabeprazole Sodium api active pharmaceuticals ingredients Rabeprazole Sodium manufacturers Side Effects bulk drugs raw material Rabeprazole Sodium companies Side Effects Importers Rabeprazole Sodium Rabeprazole Sodium Exporters Rabeprazole Sodium exporters FDA Rabeprazole Sodium DMF Symptoms Generic Taj Pharmaceuticals Ltd.

Pharmaceuticals API Manufacturer Rabeprazole Sodium, Rabeprazole Sodium manufacturer India, Rabeprazole Sodium product, Rabeprazole Sodium products, Api preparation, Certificate of Analysis API manufacturer product, Rabeprazole Sodium anti ulcer product, Certificate of Origin COA Rabeprazole Sodium COS Rabeprazole Sodium, pharmaceutical generic, pharmaceutical drug, medical, Rabeprazole Sodium pharma healthcare, pharma patents, contract MSDS manufacturing Trader Rabeprazole Sodium pharma, generic pharma, HCL pharma MSDS pharmaceutical products, pharmaceutical formulations, generic import API, Rabeprazole Sodium expectorant Pharmaceutical GMP Method of analysis formulations manufacturer, Rabeprazole Sodium DMF drug master file pharmaceutical Anti Cancer active ingredient exporter from India, pharma Rabeprazole Sodium ingredients, api, HIV Rabeprazole Sodium, tablets, capsules, syrup & protein Rabeprazole Sodium powder, GMP of Plant api nutraceuticals, gynec products, ortho ingredients in India, oncology products, Rabeprazole Sodium gastroenterology products, buy, sell orthopaedic product, who gmp, cGMP, US FDA, Rabeprazole Sodium WHO, UKMHRA Approval

   PRODUCT LIST
   Home
   API >>>
   Pharmaceuticals API List
   Chemicals
   Manufacturing
   Product Development
   Product Search
   Agro Chemicals
   Custom Pharma Services
   Contact Us
 
Rabeprazole sodium blocks acid production in the stomach











 








 

 
HOME >> Pharmaceuticals API List 3 >> Rabeprazole Sodium >> Drug Description

Rabeprazole Sodium CAS Number 117976-89-3

DRUG DESCRIPTION
Rabeprazole Sodium CAS Number 117976-89-3


The active ingredient in Delayed-Release Tablets is rabeprazole sodium, a substituted benzimidazole that inhibits gastric acid secretion. Rabeprazole sodium is known chemically as 2-[[[4-(3-methoxypropoxy)-3-methyl-2-pyridinyl]-methyl]sulfinyl]-1H-benzimidazole sodium salt. It has an empirical formula of C18H20N3NaO3S and a molecular weight of 381.43. Rabeprazole sodium is a white to slightly yellowish-white solid. It is very soluble in water and methanol, freely soluble in ethanol, chloroform and ethyl acetate and insoluble in ether and n-hexane. The stability of rabeprazole sodium is a function of pH; it is rapidly degraded in acid media, and is more stable under alkaline conditions

Tablet is available for oral administration as delayed-release, enteric-coated tablets containing 20 mg of rabeprazole sodium.

Inactive ingredients of the 20 mg tablet are carnauba wax, crospovidone, diacetylated monoglycerides, ethylcellulose, hydroxypropyl cellulose, hypromellose phthalate, magnesium stearate, mannitol, propylene glycol, sodium hydroxide, sodium stearyl fumarate, talc, and titanium dioxide. Iron oxide yellow is the coloring agent for the tablet coating. Iron oxide red is the ink pigment.

Rabeprazole sodium blocks acid production in the stomach. It is prescribed for the short-term (4 to 8 weeks) treatment of sores and inflammation in the upper digestive canal (esophagus). This condition, known as gastroesophageal reflux disease (GERD), is caused by the backflow of stomach acid into the esophagus over a prolonged period of time. Because GERD can be chronic, your doctor may continue to prescribe Rabeprazole sodium to prevent a relapse after your initial course of treatment and to relieve symptoms of GERD such as heartburn.

Rabeprazole sodium can also be prescribed for the short-term (up to 4 weeks) treatment of duodenal ulcers (ulcers that form just outside the stomach at the top of the small intestine), and for Zollinger-Ellison syndrome, a disease which causes the stomach to produce too much acid. The drug is classified as a "proton pump inhibitor." It works by blocking a specific enzyme essential to the production of stomach acid. It begins reducing acid within an hour of administration.

Information Associated with Product:
DRUG DESCRIPTION >>
DOSAGE
SIDE EFFECTS
PRECAUTIONS
INTERACTION
CONSUMER INFORMATION
 
 
PDF DOWNLOAD WORD DOCUMENT
Product Enquiry Product Quotation Sample Request Place Your Order  
Product Enquiry Product Quotation Sample Request Place Your Order  

Taj pharmaceuticals API Logo

Rabeprazole Sodium

More Api at Taj Pharmaceuticals Ltd.

Quetiapine Fumarate

Quinine Sulfate

Rabeprazole Sodium

Ramipril

Ranitidine Hydrochloride

Risperidone

Rivastigmine Tartrate

Rizatriptan

Rosiglitazone Maleate

Telmisartan

Tamsulosin HCl

Tegaserod Maleate

Terbinafine HCl

Tolterodine Tartrate

Trandolapril

Valdecoxib

Valsartan

Venlafaxine

Voriconazole

Zolmitriptan

Zonisamide

Primidone

Copyright © Taj Pharmaceuticals Ltd. | Privacy Policy | Terms & Conditions | Sitemap

Investor Relations    Feedback     Contact Worldwide    Sitemap
 

taj group logo
© 2004 - 2009 Taj Pharmaceuticals Limited . All rights reserved
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this web site is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your health care provider.
Additionally, contact information on this web site cannot be used to report adverse drug events. If you are a physician, please follow the procedures required by your country's regulations. Please choose one of the given options to contact us and we will respond to your inquiry as quickly as possible.